Sun Pharma, Taro Pharmaceutical reach $75M settlement agreement in alleged price fixing scheme
The Indian multinational drugmaker Sun Pharma, alongside Israel’s Taro Pharmaceutical Industries, is cashing out tens of millions to settle a lawsuit in a US federal court.
In a motion dated Thursday, federal judge Cynthia M. Rufe out of Pennsylvania’s eastern district signed off on a settlement that would resolve antitrust litigation involving Sun Pharma and Taro Pharmaceuticals. The eight-page order detailed that the value was set for $75 million, with the chance for another $20 million to be added based on specific clauses in the settlement agreement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.